Patrice P. Denefle
Chief Tech/Sci/R&D Officer bei CENTOGENE N.V.
Profil
Patrice P.
Denefle is currently the Chief Scientific Officer at Centogene NV since 2021.
Prior to this, he held the same position at Genethon and 4P-Pharma.
He completed his undergraduate degree at Université De Lille.
Aktive Positionen von Patrice P. Denefle
| Unternehmen | Position | Beginn |
|---|---|---|
| CENTOGENE N.V. | Chief Tech/Sci/R&D Officer | 16.08.2021 |
Ehemalige bekannte Positionen von Patrice P. Denefle
| Unternehmen | Position | Ende |
|---|---|---|
| 4P-Pharma | Chief Tech/Sci/R&D Officer | - |
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Patrice P. Denefle
| Université De Lille | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CENTOGENE N.V. | Commercial Services |
| Private Unternehmen | 2 |
|---|---|
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Health Technology |
| 4P-Pharma |
